Omniscan

Therapeutic Group

Indication Dosage

Gadodiamide is a gadolinium-based contrast agent (GBCA) used in diagnostic imaging procedures, specifically magnetic resonance imaging (MRI), to improve the visibility of certain tissues and blood vessels.

It is indicated for use in:

• Brain and spinal cord imaging: Gadodiamide can be used to enhance the visibility of certain structures in the brain and spinal cord, such as lesions, tumors, and areas of inflammation or infection.
• Liver imaging: Gadodiamide can be used to help detect and evaluate liver lesions, such as tumors or cysts, and to distinguish between different types of liver tissue.
• Kidney imaging: Gadodiamide can be used to help diagnose and evaluate kidney disorders, such as tumors, cysts, or obstructions.
• Whole-body imaging for tumor detection: Gadodiamide can be used as part of an MRI scan of the whole body to help detect and evaluate the presence of tumors or other abnormalities.

Dosage:

• MRI of the head and neck: 0.1 mmol/kg
• MRI of the body: 0.2 mmol/kg

Content

Pregnancy

Consult With Your Doctor

Stability

Contra Indications

Precautions

Lactation

Side Effects